Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Standard Medication”

385 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 385 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07796100
What this trial is testing

ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 530
Large-scale testing (Phase 3)Study completedNCT05840341
What this trial is testing

Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Fudan University 305
Testing effectiveness (Phase 2)Study completedNCT04325594
What this trial is testing

The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure

Who this might be right for
Chronic Heart FailureNon-ischemic CardiomyopathyNon-ischemic Dilated Cardiomyopathy
The Research-Clinical Center for Cardiac Surgery and Transplantology LLP 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07736950
What this trial is testing

A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Australasian Leukaemia and Lymphoma Group 138
Testing effectiveness (Phase 2)Ended earlyNCT02481960
What this trial is testing

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

Who this might be right for
Glioma
Boston Scientific Corporation 5
Post-approval studies (Phase 4)Looking for participantsNCT06090890
What this trial is testing

Anti-inflammatory Therapy for Recurrent In-stent Restenosis

Who this might be right for
In-stent Restenosis
Fu Wai Hospital, Beijing, China 252
Not applicableUnknownNCT01976325
What this trial is testing

Evaluating the Ottawa Malaria Decision Aid

Who this might be right for
Malaria
Ottawa Hospital Research Institute 100
Testing effectiveness (Phase 2)Study completedNCT04834674
What this trial is testing

DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaTransarterial ChemoembolizationApatinib+1 more
Sichuan Cancer Hospital and Research Institute 20
Large-scale testing (Phase 3)Study completedNCT00495326
What this trial is testing

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Who this might be right for
TuberculosisAidsHiv Infections
French National Agency for Research on AIDS and Viral Hepatitis 570
Large-scale testing (Phase 3)Ended earlyNCT00000730
What this trial is testing

Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Testing effectiveness (Phase 2)Study completedNCT05829187
What this trial is testing

Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency

Who this might be right for
Uncomplicated Plasmodium Falciparum
Syamsudin Abdillah,Ph.D, Pharm D 36
Early research (Phase 1)Ended earlyNCT01705106
What this trial is testing

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Chicago 21
Not applicableStudy completedNCT03495869
What this trial is testing

Feasibility and Validation of a Standard Phenotyping Assessment Battery

Who this might be right for
Opioid-use DisorderCocaine Use DisorderMarijuana Use Disorder+1 more
Virginia Commonwealth University 368
Not applicableUnknownNCT04825925
What this trial is testing

Drug-eluting Beads Bronchial Arterial Chemoembolization in Stage II-III Non-small-cell Lung Cancer Patients Failed, Refused or Ineligible to Receive Standard Treatments

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableStudy completedNCT06231407
What this trial is testing

Increasing Medication Check Participation Through Applying CT-r

Who this might be right for
Schizophrenia and Related Disorders
Vanderbilt University Medical Center 26
Not applicableStudy completedNCT05932290
What this trial is testing

Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 514
Post-approval studies (Phase 4)Study completedNCT02083991
What this trial is testing

Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

Who this might be right for
Diabetes Mellitus
Vastra Gotaland Region 224
Not applicableStudy completedNCT03339102
What this trial is testing

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

Who this might be right for
Non-infectious Intermediate, Posterior and Panuveitis
AbbVie 158
Large-scale testing (Phase 3)Active Not RecruitingNCT04799275
What this trial is testing

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IIX (Bulky) Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma+18 more
National Cancer Institute (NCI) 422
Not applicableLooking for participantsNCT07364175
What this trial is testing

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Who this might be right for
HypertensionObesity & Overweight
Cambridge University Hospitals NHS Foundation Trust 60
Next Page